Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - chondroitin sulfate - capsule, hard - 400 milligram(s) - antiinflammatory and antirheumatic products

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 75 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 150 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 150 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 75 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 225 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 300 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - diclofenac epolamine - medicated plaster - 140 milligram(s) - antiinflammatory preparations, non-steroids for topical use; diclofenac

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - diclofenac epolamine - medicated plaster - diclofenac

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - 44670 - bladder instillation, barrier - procedure pack consisting of a clear plastic pre-filled syringe containing a sterile aqueous solution of hyaluronic acid sodium salt (1.6%), sodium chondroitin sulphate (2%) and calcium chloride administered as a bladder instillation via connection to a catheter using the leur lock adaptor and the ialuadapter included in the pack. the ialuadapter allows for administration by either the patient or healthcare professional. ialuril is indicated to re-establish the glycosaminoglycan layers (gags) of the urothelial vesical tissue in cases in which their loss can cause frequent and recurring problems such as painful bladder syndrome (pbs), interstitial cystitis, treatment and prevention of recurrent urinary tract infection, cystitis as a result of bacillus calmette ? guerin therapy, or chemical and radiation therapy. ialuril is also indicated in the cases where the loss of the glycosaminoglycan layers (gags) is associated with forms of chronic inflammation, in which their composition and integrity appears compromised in different ways.